Abich Financial Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Abich Financial Wealth Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$67K	Buy	+147	New	+$59.9K	0.02%	273

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Abich Financial Wealth Management's ALNY Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2025: 147 shares worth $67K. The stake represents 0.02% of the portfolio and ranks #273 among its holdings.

822 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

Abich Financial Wealth Management held 147 shares of Alnylam Pharmaceuticals worth $67K as of Q3 2025.
Alnylam Pharmaceuticals was a new Abich Financial Wealth Management position in Q3 2025.
Alnylam Pharmaceuticals made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2025, its #273 holding.
822 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.